Results 181 to 190 of about 136,755 (290)

Drastic Response to Olaparib in a Patient With Metastatic Castration‐Resistant Prostate Cancer Harboring BRCA2 Alterations and Near‐Threshold Tumor Mutational Burden

IJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction BRCA2 alterations and high tumor mutational burden (TMB‐H) are responsible for prostate cancer; however, their co‐occurrence is uncommon, and evidence for PARP inhibition in the castration‐sensitive setting remains limited. We describe a case of metastatic castration‐resistant prostate cancer (CRPC) harboring both biomarkers ...
Kotaro Yokota, Takeo Kosaka, Tatsuaki Daimon, Shinnosuke Fujiwara, Kohei Nakamura, Hiroshi Nishihara, Mototsugu Oya   +6 more
wiley   +1 more source

Ovarian Neuroendocrine Neoplasms: Challenges and Future Perspectives. [PDF]

J Clin Med
Di Vito V, Veroi G, Rizza L, Rota F, Baiocchini A, Macciomei MC, Lubrano C, La Salvia A, Lania A, Grillo LR, Migliaccio S, Rindi G, Baldelli R.   +12 more
europepmc   +1 more source

Bladder Neuroendocrine Carcinoma [PDF]

, 2020
openaire   +1 more source

Non‐Functional Paraganglioma of the Urinary Bladder: A Rare Cause of Bladder Tumor

IJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Paragangliomas of the urinary bladder (PUBs) are rare neuroendocrine tumors, representing less than 0.06% of all bladder neoplasms. While most are functional and associated with catecholamine excess, approximately 15% are non‐functional, often presenting asymptomatically and discovered incidentally.
Matt Wainstein, Vivek Aslot, Faith Dennie, Mark Wainstein, Thenappan Chandrasekar   +4 more
wiley   +1 more source

Glucose-transporter 1 (GLUT1) as a prognostic biomarker: evidence from 14,966 human tumors across 134 cancer types. [PDF]

BMC Cancer
Büyücek S, Möller K, Viehweger F, Schlichter R, Menz A, Luebke AM, Reiswich V, Kluth M, Hube-Magg C, Hinsch A, Lutz F, Weidemann S, Jacobsen F, Lennartz M, Dum D, Bernreuther C, Lebok P, Sauter G, Marx AH, Simon R, Fraune C, Gorbokon N, Burandt E, Minner S, Steurer S, Clauditz TS, Krech T, Chirico V.   +27 more
europepmc   +1 more source

Membrane proeteins as markers for normal and neoplastic endocrine cells [PDF]

, 1993
Gratzl, Manfred, Lahr, G., Wagener, Christoph   +2 more
core  

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, Volume 46, Issue 2, Page 475-512, March 2026.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

Primary large cell neuroendocrine carcinoma of the breast diagnosed using dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging: A case report. [PDF]

Medicine (Baltimore)
Kim B, Choi S, Kim KM, Choi EJ.
europepmc   +1 more source

Appendix Neuroendocrine Carcinoma [PDF]

, 2020
openaire   +1 more source

Local Anesthetics in Cancer: Mechanisms and Translational Perspectives

MedComm – Oncology, Volume 5, Issue 1, March 2026.
Local anesthetics demonstrate multifaceted antitumor effects that collectively contribute to cancer suppression. Beyond canonical sodium channel blockade, these agents exert the following pharmacological actions: inhibition of tumor cell proliferation, suppression of migration and invasion, induction of proapoptotic pathways, attenuation of ...
Wan‐li Wang, Tu Huang, Yi‐hang Hao, Min Zheng, Xin‐hua Liang   +4 more
wiley   +1 more source